Search earnings tickers

VRTX

2026Q1AMC

Vertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-05-04 · Fiscal end 2026-03-31 · Features as of 2026-05-04

← Earnings history

Street

Consensus EPS4.306

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.6%

IV front—

P/C full—

P/C front—

Features as of2026-05-04

Run-up

Close—

Ret 5d+0.9%

Ret 10d-2.1%

Ret 20d-1.0%

Ret 30d-5.3%

Print

Actual EPS

4.47Beat

Estimated EPS4.306

Actual revenue

3.0B

Surprise %+3.8%

Beat / missBeat

Beat streak 41

Beat streak 81

Reaction

1-day stock reaction-1.8%

Implied vs actual

Implied 2.6%Actual 0.5%

Gap reaction+0.5%

Day result-1.3%

Next-day upNo

Realized / IV0.19×

Post tape

Post 5d+5.6%

Post 10d+2.3%

Post volume1.9M

Vol ×10d1.95×

Vol ×20d1.80×

Post range5.0%